TY - JOUR
T1 - Agnostic B cell selection approach identifies antibodies against K. pneumoniae that synergistically drive complement activation
AU - van der Lans, Sjors P.A.
AU - Bardoel, Bart W.
AU - Ruyken, Maartje
AU - de Haas, Carla J.C.
AU - Baijens, Stan
AU - Muts, Remy M.
AU - Scheepmaker, Lisette M.
AU - Aerts, Piet C.
AU - van ’t Wout, Marije F.L.
AU - Preiner, Johannes
AU - Marijnissen, Renoud J.
AU - Schuurman, Janine
AU - Beurskens, Frank J.
AU - Kerkman, Priscilla F.
AU - Rooijakkers, Suzan H.M.
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - Antibody-dependent complement activation plays a key role in the natural human immune response to infections. Currently, the understanding of which antibody-antigen combinations drive a potent complement response on bacteria is limited. Here, we develop an antigen-agnostic approach to stain and single-cell sort human IgG memory B cells recognizing intact bacterial cells, keeping surface antigens in their natural context. With this method we successfully identified 29 antibodies against K. pneumoniae, a dominant cause of hospital-acquired infections with increasing antibiotic resistance. Combining genetic tools and functional analyses, we reveal that the capacity of antibodies to activate complement on K. pneumoniae critically depends on their antigenic target. Furthermore, we find that antibody combinations can synergistically activate complement on K. pneumoniae by strengthening each other’s binding in an Fc-independent manner. Understanding the molecular basis of effective complement activation by antibody combinations to mimic a polyclonal response could accelerate the development of antibody-based therapies against problematic infections.
AB - Antibody-dependent complement activation plays a key role in the natural human immune response to infections. Currently, the understanding of which antibody-antigen combinations drive a potent complement response on bacteria is limited. Here, we develop an antigen-agnostic approach to stain and single-cell sort human IgG memory B cells recognizing intact bacterial cells, keeping surface antigens in their natural context. With this method we successfully identified 29 antibodies against K. pneumoniae, a dominant cause of hospital-acquired infections with increasing antibiotic resistance. Combining genetic tools and functional analyses, we reveal that the capacity of antibodies to activate complement on K. pneumoniae critically depends on their antigenic target. Furthermore, we find that antibody combinations can synergistically activate complement on K. pneumoniae by strengthening each other’s binding in an Fc-independent manner. Understanding the molecular basis of effective complement activation by antibody combinations to mimic a polyclonal response could accelerate the development of antibody-based therapies against problematic infections.
KW - Humans
KW - Complement Activation/immunology
KW - Antibodies, Bacterial/immunology
KW - Klebsiella pneumoniae/immunology
KW - Immunoglobulin G/immunology
KW - B-Lymphocytes/immunology
KW - Memory B Cells/immunology
UR - http://www.scopus.com/inward/record.url?scp=85204302996&partnerID=8YFLogxK
U2 - 10.1038/s41467-024-52372-9
DO - 10.1038/s41467-024-52372-9
M3 - Article
C2 - 39285158
AN - SCOPUS:85204302996
SN - 2041-1723
VL - 15
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 8100
ER -